Glaxosmithkline Pharmaceuticals has informed that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is closed from Friday, 1st January, 2021 and shall reopen on Wednesday, 10th February, 2021 i.e. after the approval and declaration of Un-audited Financial Results for the quarter and nine months ended 31st December, 2020 by the Board of Directors at its meeting scheduled to be held on 5th February 2021.
The above information is a part of company’s filings submitted to BSE.
